ACST - Acasti Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ACST is currently covered by 2 analysts with an average price target of $26.53. This is a potential upside of $23.16 (687.24%) from yesterday's end of day stock price of $3.37.

Acasti Pharma's activity chart (see below) currently has 6 price targets and 11 ratings on display. The stock rating distribution of ACST is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 36.25 days.

Highest price target for ACST is $12, Lowest price target is $12, average price target is $12.

Most recent stock forecast was given by OREN LIVNAT from HC WAINWRIGHT on 26-Sep-2024. First documented stock forecast 13-Jan-2020.

Best performing analysts who are covering ACST - Acasti Pharma:

Leland Gershell Mayank Mamtani Constantine Davides Oren Livnat

Currently out of the existing stock ratings of ACST, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$12

$8.63 (256.08%)

$12

11 months 17 days ago
(26-Sep-2024)

0/2 (0%)

$8.93 (290.88%)

Buy

$2.5

$-0.28 (-10.07%)

2 years 6 months 28 days ago
(15-Feb-2023)

1/1 (100%)

$1.86 (290.63%)

145

Buy

$30

3 years 2 months 21 days ago
(22-Jun-2022)

0/2 (0%)

$22.32 (290.63%)

Buy

5 years 12 days ago
(31-Aug-2020)

0/1 (0%)

$59.52 (163.16%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACST (Acasti Pharma) average time for price targets to be met?

On average it took 36.25 days on average for the stock forecasts to be realized with a an average price target met ratio 25

Which analyst has the current highest performing score on ACST (Acasti Pharma) with a proven track record?

LELAND GERSHELL

Which analyst has the current lower performing score on ACST (Acasti Pharma) with a proven track record?

OREN LIVNAT

Which analyst has the most public recommendations on ACST (Acasti Pharma)?

Leland Gershell works at OPPENHEIMER and has 2 price targets and 2 ratings on ACST

Which analyst is the currently most bullish on ACST (Acasti Pharma)?

Oren Livnat with highest potential upside - $8.63

Which analyst is the currently most reserved on ACST (Acasti Pharma)?

Constantine Davides with lowest potential downside - -$0.28

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?